Table 2.

Hb responder analysis

		Number of		Percent with
Outcome	Comparator	Trials	Patients	Ferric carboxymaltose	Control	RB 95% CI	NNT 95% CI
Target Hb increase	All	6	1715	78	63	1.2 (1.2 to 1.3)	6.8 (5.3 to 9.7)
	Oral iron	5	1481	74	59	1.3 (1.2 to 1.4)	6.6 (5.0 to 9.6)
Achieve target Hb level	Oral iron	5	1509	79	62	1.3 (1.2 to 1.4)	5.9 (4.7 to 8.1)
Clinical success	All	4	1167	70	2	37 (20 to 67)	1.5 (1.4 to 1.6)
	Oral iron	3	984	78	0	250 (51 to 1190)	1.3 (1.2 to 1.3)